Godrej Agrovet Q3 FY26: Revenue Hits ₹2,718 Cr

Key numbers at a glance

Godrej Agrovet reported a stronger Q3 FY26 on the topline, with consolidated net sales rising to ₹2,718.32 crore. Net profit came in at ₹114.82 crore, marking a sequential recovery from Q2 FY26. But profitability remained constrained, with the operating margin (excluding other income) at 8.90%, still below the 9.00% level seen a year ago. The quarter matters because it pairs the company’s highest quarterly revenue in recent history with signs that cost pressures are not easing fast enough.

What drove the quarter

The company attributed the revenue strength to favourable demand dynamics across the animal nutrition and crop protection segments. Net sales hit ₹2,718.32 crore in Q3 FY26, the strongest quarterly performance in the trailing twelve-month period. This print also exceeded the earlier peak of ₹2,614.29 crore recorded in Q1 FY26. The topline trend indicates resilience in demand, even as profitability metrics show only limited improvement.

Topline strength, bottomline mixed

On a quarter-on-quarter basis, Q3 FY26 revenue increased 5.88% from ₹2,567.42 crore in Q2 FY26. Year-on-year, revenue expanded 10.97% from ₹2,449.63 crore in Q3 FY25. Net profit rose 24.01% sequentially from ₹92.59 crore in Q2 FY26. However, the year-on-year increase in profit was a modest 2.99% over ₹111.49 crore in Q3 FY25, underscoring that revenue growth has not translated into similar profit growth.

Margins show pressure despite growth

Operating profit (PBDIT excluding other income) rose to ₹241.56 crore, up 13.18% QoQ from ₹213.40 crore. On a YoY basis, it increased 9.78% from ₹220.03 crore. The operating margin improved by 58 basis points QoQ to 8.90% from 8.32%, but it declined 10 basis points YoY from 9.00%. The PAT margin stood at 4.04%, improving from 3.29% in Q2 FY26 but falling from 4.49% in the year-ago quarter.

Cost inflation signals limited pricing power

The margin compression, despite record revenue, points to rising costs that the company has struggled to pass through fully. The article flagged inflation across raw materials, employee expenses, and operational overheads as a continuing theme. Employee costs rose to ₹165.61 crore in Q3 FY26 from ₹164.58 crore in Q2 FY26, a 0.63% sequential increase. Year-on-year, employee costs climbed 17.60% from ₹140.82 crore in Q3 FY25. With operating margin still below last year, cost control and execution will remain central to near-term earnings quality.

Quarterly trend shows volatility

The sequence of quarterly numbers highlights fluctuating margins and profits even as sales have trended higher over time. Q1 FY26 recorded a 10.36% operating margin and net profit of ₹160.52 crore, followed by a sharp profit drop in Q2 FY26 and then a recovery in Q3 FY26. This pattern supports the “bottomline volatility” framing in the article. It also aligns with the “Flat” financial trend classification referenced for December 2025.

Leverage and interest costs in focus

Beyond the P&L, the balance-sheet commentary stood out. Debt-to-equity was reported at 1.19 times for H1 FY26, described as the highest leverage level in recent quarters. The interest burden in Q3 FY26 was ₹34.68 crore, and interest coverage was cited at 4.22 times (EBIT/Interest). Higher leverage can limit financial flexibility and increase sensitivity to earnings swings, especially when operating margins are not expanding meaningfully.

Returns: ROE remains a relative strength

The company’s return on equity averaged 17.51% over the past five years, which the article positioned as a favourable comparison versus many peers. It also noted the latest ROE of 24.05% as elevated relative to the historical average. The piece cautioned that the higher ROE could reflect a compressed equity base due to dividend distributions and share buybacks, rather than purely stronger profit growth.

Stock performance and market context

Godrej Agrovet’s stock underperformed over the past year, falling 27.62% and lagging the Sensex gain of 8.49%. The stock was quoted at ₹548.65 as of February 03, 2026, and was down 37.39% from its 52-week high of ₹876.30. The article also cited a 52-week low support level at ₹506.70. In the same period, the FMCG sector’s one-year return was -1.60%, suggesting the stock’s decline reflected company-specific concerns beyond broader sector headwinds.

Valuation discount versus sector

On valuation, the stock traded at a trailing P/E of 24.24 times compared with the FMCG sector average of 52 times. The article framed this gap as a discount driven by concerns around growth sustainability, margins, and leverage. It also referenced a PEG ratio of 2.48 times and highlighted five-year sales growth of 7.86% and EBIT growth of 8.43% as part of the context for the valuation debate.

What management and investors are watching next

The outlook section highlighted that margin recovery depends on raw material cost stabilisation and operational efficiencies. It also flagged deleveraging as a key monitorable, given the 1.19x debt-to-equity and the related interest load. A supporting datapoint was operating cash flow of ₹969 crore in FY25, cited as providing capacity for debt reduction. The article also pointed to favourable monsoon forecasts and government thrust on agricultural productivity as potential tailwinds for volumes, while noting intense competition in animal nutrition and crop protection.

Conclusion

Godrej Agrovet’s Q3 FY26 delivered record revenue of ₹2,718.32 crore and a sequential profit recovery to ₹114.82 crore, but margins and leverage remain the central investor concerns. The next few quarters will be watched for sustained operating margin improvement and evidence of balance-sheet deleveraging.